Engineered PD-L1 Nanoregulators for Enhanced Tumor Immunotherapy

Program death ligand 1 (PD-L1) pathway plays a central role in enabling tumors to escape immune detection, making it a prime target for cancer immunotherapy. While immune checkpoint inhibitors (ICIs)...